Nehybová, T.; Šmarda, J.; Daniel, L.; Stiborek, M.; Kanický, V.; Spasojevič, I.; Preisler, J.; Damborský, J.; Beneš, P.
Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells. Int. J. Mol. Sci. 2017, 18, 729.
https://doi.org/10.3390/ijms18040729
AMA Style
Nehybová T, Šmarda J, Daniel L, Stiborek M, Kanický V, Spasojevič I, Preisler J, Damborský J, Beneš P.
Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells. International Journal of Molecular Sciences. 2017; 18(4):729.
https://doi.org/10.3390/ijms18040729
Chicago/Turabian Style
Nehybová, Tereza, Jan Šmarda, Lukáš Daniel, Marek Stiborek, Viktor Kanický, Ivan Spasojevič, Jan Preisler, Jiří Damborský, and Petr Beneš.
2017. "Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells" International Journal of Molecular Sciences 18, no. 4: 729.
https://doi.org/10.3390/ijms18040729
APA Style
Nehybová, T., Šmarda, J., Daniel, L., Stiborek, M., Kanický, V., Spasojevič, I., Preisler, J., Damborský, J., & Beneš, P.
(2017). Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells. International Journal of Molecular Sciences, 18(4), 729.
https://doi.org/10.3390/ijms18040729